FDA Inspection
Paul Harmatz, M.D.Paul Harmatz, M.D. – FDA Inspection, Jun 16, 2017
Record Details
This FDA Inspection record concerns Paul Harmatz, M.D., with an inspection on June 16, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.
- Person
- Dustin P. Tran (Issuing Officer)
View Company Profile
ID · e5ba9ca4-8a82-49e6-b10f-e497c7f9f381
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1014482
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
- Outcome
- Form 483 issued
FDA Citations
1- 21 CFR 312.62(b)Case history records- inadequate or inadequate
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Paul Harmatz, M.D.
4| Date | Classification | Office | Project area |
|---|---|---|---|
| August 21, 2025 | NAI | Center for Biologics Evaluation and Research | Bioresearch Monitoring |
| November 5, 2020 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| October 16, 2020 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| October 2, 2013 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Paul Harmatz, M.D.
- FDA Inspection 1280024 - 2025-08-21
- FDA Inspection 1131540 - 2020-11-05
- FDA Inspection 1131717 - 2020-10-16
- FDA Inspection 849987 - 2013-10-02
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.